Laboratory of Molecular Neurosurgery, Institute of Neurological Sciences, Marmara University, Istanbul 34853, Turkey.
J Clin Neurosci. 2010 Feb;17(2):232-6. doi: 10.1016/j.jocn.2009.06.008. Epub 2009 Dec 29.
This study aimed to compare cerebral arteriovenous malformations (cAVM) and cerebral cavernous malformations (CCM) with regard to the immunohistochemical expressions of matrix metalloproteinases (MMP) and selected extracellular matrix (ECM) proteins, which have a role in the regulation of angiogenesis. Fresh-frozen surgical specimens from patients with cAVM (n=14) and CCM (n=15) were immunohistochemically stained with antibodies for MMP-2, MMP-9, laminin, fibronectin and tenascin. To compare cAVM and CCM, expression of each protein was graded using a four-point scoring system for each histological layer of the lesion. MMP-2 and MMP-9 were more strongly expressed in the vascular walls of CCMs compared to cAVMs for all comparable layers: endothelium, subendothelium and the perivascular space. The stronger expression of MMP and other EMP associated with early angiogenesis in CCMs compared to AVMs may support the hypothesis that CCMs occur at earlier embryogenic stages than AVMs.
本研究旨在比较脑动静脉畸形(cAVM)和脑海绵状血管畸形(CCM)在基质金属蛋白酶(MMP)和选定的细胞外基质(ECM)蛋白免疫组织化学表达方面的差异,这些蛋白在血管生成的调节中发挥作用。对来自 cAVM(n=14)和 CCM(n=15)患者的新鲜冷冻手术标本进行 MMP-2、MMP-9、层粘连蛋白、纤维连接蛋白和腱蛋白免疫组织化学染色。为了比较 cAVM 和 CCM,使用四点评分系统对病变的每个组织学层的每种蛋白表达进行分级。在所有可比层(内皮、内皮下层和血管周围腔)中,CCM 的血管壁中 MMP-2 和 MMP-9 的表达均强于 cAVM。与 AVM 相比,CCM 中 MMP 和其他与早期血管生成相关的 EMP 的更强表达可能支持 CCM 发生在比 AVM 更早的胚胎发生阶段的假说。